Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
During the last 3 months Brainstorm Cell Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 16% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/bcli/vs/indx/gspc">open performance analysis).
The last transaction was made on
Oct 1, 2024
by
Lebovits Chaim
, who
bought
6.3k USD
worth of
BCLI shares.
During the last 3 months Brainstorm Cell Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 16% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/bcli/vs/indx/gspc">open performance analysis).
The last transaction was made on
Oct 1, 2024
by
Lebovits Chaim
, who
bought
6.3k USD
worth of
BCLI shares.
Brainstorm Cell Therapeutics Inc
Glance View
Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. The company is headquartered in New York City, New York and currently employs 43 full-time employees. The company went IPO on 2003-05-28. The firm is focused on the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), Alzheimer's disease (AD), and other neurodegenerative diseases. NurOwn, its cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells (MSCs) to secrete high levels of neurotrophic factors (NTFs), modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. NurOwn has completed its phase III ALS and phase II PMS clinical trials. Its wholly owned subsidiary, BrainStorm Cell Therapeutics Ltd. holds the rights to commercialize its NurOwn technology. Its other subsidiaries include Advanced Cell Therapies Ltd., and two others.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.